Analysis of the hottest pharmaceutical packaging m

Analysis of China's pharmaceutical packaging market (Part 2)

the quality needs to be improved - there are business opportunities in the backwardness

the annual output value is 15billion, with an annual growth of more than 10%

at present, China's pharmaceutical packaging industry has more than 2000 large and small enterprises, which can produce more than 30 varieties of pharmaceutical packaging materials in six categories, which can basically meet the needs of the domestic pharmaceutical industry, and the annual sales have accounted for about 15% of the sales of the whole pharmaceutical industry. At present, the annual output value of China's pharmaceutical packaging industry is about 15billion yuan, with an annual growth rate of more than 10%

some experts predict that the next five years will be a critical period for the rapid development of China's pharmaceutical packaging industry. At present, the annual output value of China's pharmaceutical packaging industry is about 15billion yuan, which can only meet about 80% of the needs of domestic pharmaceutical enterprises. According to the development speed of China's pharmaceutical industry in recent years, the annual GDP of pharmaceutical packaging materials will quickly exceed 20billion yuan in a short time

by the end of 2003, in order to eliminate everyone's confusion, China's pharmaceutical packaging material manufacturers and their raw material suppliers had ordered 24 PET production lines from the world's three major pet (polyethylene terephthalate) production line suppliers. This number seems small, but it is actually quite amazing, because PET film is the main raw material of composite film for pharmaceutical packaging, and launching a large PET production line often costs tens of millions of dollars. No enterprise dares to invest money in it easily, which shows how attractive the potential of China's pharmaceutical packaging industry is

flexible packaging will dominate in a short time

according to the American flexible packaging Association, in the next five years, drug packaging will become the second largest economic growth point of flexible packaging. The report also pointed out that in addition to the strong development momentum of medical supplies, the packaging of medical supplies is also developing rapidly. The replacement of bulk or bottled drug packaging with thermoformed extruded blister packaging with controllable dose has begun to appear. From the current application and development of pharmaceutical packaging containers in China, we should speed up the promotion and application of plastic containers for pharmaceutical oral liquids. Its specifications range from 100 ml to 200 ml. the raw materials used are polyethylene terephthalate (PET) and new materials pen, including the development of high-quality pet plastic bottles that are dark and have scales on the containers or attached with measuring cups on January 28, 2013, to replace low-quality glass bottles. As the pills, capsules and powders of traditional Chinese medicine in China have a large development space in the international market, it is also necessary to speed up the development of plastic hollow container packaging of traditional Chinese medicine. For example, plastic hollow containers made of high-density polyethylene (HDPE), polypropylene (PP), pet, pen and other materials are used, and injection blow molding and injection drawing blow molding processes are adopted. The mouth of the hollow container is sealed with aluminum foil electromagnetic induction gasket to increase the safety protection of the packaging container for drugs, and eliminate the backward packaging of drugs with yellow round glass bottle sealing wax

polyester plastic bottle is one of the most important drug packaging materials at present. As a drug packaging container, pet has many advantages. First, PET bottle is light and firm, and its strength and elasticity are significantly higher than those of containers made of other plastic materials. It can withstand considerable impact without damage. It is most suitable for making drug packaging bottles with thin wall, light weight and high strength. With the same volume of medicine, the weight of PET bottle is only 1/10 of that of glass bottle. The volume of PET bottle with the same outer diameter is 15 times that of glass bottle. Medical PET bottles have good gas barrier property. Among the commonly used plastics, PET bottles have the best performance of blocking water vapor and oxygen, which can fully meet the special storage requirements of drug packaging. PET bottles also have excellent chemical resistance, and can be used for the packaging of all items except strong alkali and some organic solvents. The recycling rate of PET resin is higher than that of other plastics. When it is burned as waste, its combustion heat card value is low and flammable, and it does not produce harmful gases

3billion infusion packaging contains business opportunities

at present, 90% of large infusion in China are packaged in glass bottles and soft plastic packaging, and the actual production is less than 200million bottles (bags). At present, most foreign infusion agents are packed in high-quality plastic bottles or bags. The per capita infusion volume in developed countries is 3.33 bottles, which is undoubtedly a very large market. At present, the world's large infusion production volume is 12billion bottles, and China accounts for 3billion bottles. Therefore, since 2001, the reconstruction, expansion and new production of infusion packaging has become a "hot spot". Infusion packaging is mainly divided into plastic bottles and plastic bags. Since last year, BOPP bottles have sprung up. Dongguan Jiahong machinery company has developed domestic BOPP infusion bottle manufacturing equipment, which uses two-step injection, drawing and blowing PP bottle production equipment to produce bottles every hour, which is deeply welcomed by pharmaceutical users. Matching with other sterilization and filling equipment, BOPP infusion bottles have shown a growth momentum, changing the situation of glass bottles dominating the world. In terms of soft plastic bags, according to incomplete statistics, at present, a total of 21 enterprises have introduced or signed 25 soft plastic packaging production lines, and the production capacity of soft plastic bags is expected to reach 300million bags

China also encourages the production and use of advanced non PVC infusion soft bag packaging to further improve the water holding capacity and mechanical strength products, but at present, there are only 28 relevant production enterprises and 35 production lines in the country, and the annual output is only 90million bags, which is far from the annual demand of nearly 3billion infusion bags. PVC (polyvinyl chloride) is the most common polymer used to make intravenous bag film at present because of its low price. However, its disadvantage is that the phthalate DEHP contained in its plasticizer is suspected to cause cancer and damage the reproductive system; Long term use can lead to the accumulation of harmful substances; Dioxin will be released during deep burial and incineration, which will affect the environment. Non PVC infusion soft packaging bag is an international brand-new concept of fully closed intravenous infusion product, the first PDS monofilament suture PDS reg; Listed developed countries have been in clinical application for more than ten years. Union Medical College Hospital has studied the adsorption of 15 commonly used Chinese and Western medicines, including insulin, isosorbide nitrate, paclitaxel, Xiangdan injection, with the most commonly used glass infusion bottles in China and three infusion containers made of PVC infusion bags and non PVC infusion bags. The results show that non PVC infusion bags are the best in safety. Although the adsorption of glass bottles is very small, there are some problems, such as backflow air pollution, crack damage is difficult to detect, rubber stopper powder falls off and so on

source: Medical Herald